• Patient Access
  • Client Access
  • FAQ
Prophase Logo
open menu
  • About Us
  • Diagnostics
  • Investor Relations
    • Presentations
    • News & Events
      • Press Releases
      • Media Mentions
      • IR Calendar
      • Email Alerts
    • Company Info
      • Management Team
      • Contacts
      • FAQ
    • Financial Info
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Board of Directors
      • Board Committees
      • Governance Documents
  • Presentations
  • Press
  • Contact Us
    • Corporate
    • Diagnostics
    • TK Supplements
    • Pharmaloz

Press Releases

Investors

Investors

  • Overview
  • Presentations
  • News & Events
    • Press Releases
    • Media Mentions
    • IR Calendar
    • Email Alerts
  • Company Info
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Press Releases
  • Media Mentions
  • IR Calendar
  • Email Alerts
Mar 21, 2018 9:06am EDT

ProPhase Labs Reports Financial Results for the Year Ended December 31, 2017

Mar 16, 2018 10:23am EDT

ProPhase Labs to Release Fiscal 2017 Results on Wednesday, March 21st

Feb 20, 2018 7:15pm EST

ProPhase Labs, Inc. Announces New Compensatory Arrangement With Chief Executive Officer and Termination of Stockholder Rights Plan

Dec 21, 2017 4:00pm EST

ProPhase Labs, Inc. Announces Final Results of Its Tender Offer

Dec 19, 2017 4:30pm EST

ProPhase Labs, Inc. Announces Preliminary Results of Its Tender Offer

Nov 20, 2017 8:30pm EST

ProPhase Labs, Inc. Announces Commencement of Tender Offer to Repurchase Up to 1.7 Million Shares of Its Common Stock at Price of $2.30 Per Share

Nov 13, 2017 8:30am EST

ProPhase Labs Reports Financial Results for the Three Months and Nine Months Ended September 30, 2017

Nov 10, 2017 8:00am EST

Prophase Labs, Inc. Announces Intention to Commence Tender Offer to Repurchase Up to 1,700,000 Shares of Its Common Stock

Sep 29, 2017 8:30am EDT

ProPhase Labs, Inc. Announces Final Results of Its Tender Offer

Sep 26, 2017 4:05pm EDT

ProPhase Labs, Inc. Announces Preliminary Results of Its Tender Offer

  • arrow_back
  • 1…
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • …18
  • arrow_forward
rss_feed News RSS
  • Email Alerts
  • Contacts
  • RSS News Feed
Prophase Logo

© Copyright - ProPhase Labs, Inc.
All Rights Reserved.

  • About Us
  • Diagnostics
  • Investor Relations
  • Press
  • Contact Us
  • Site Map
  • Legal Notice
  • Accessibility